Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1998 AT-533Summary: AT-533 is a potent inhibitor. -
BA1999 FiacitabineSummary: Fiacitabine (NSC382097; FIAC; FOAC) is a selective HSVDNA replication inhibitor. -
BA2000 HN0037Summary: HN0037 is a selective, orally active deconjugulase-initiator inhibitor. -
BA2001 IsookaninSummary: Isookanin is used in studies for a variety of conditions, including tumors, rashes, snake and insect bites, diabetes, and diarrhea. -
BA2002 YateinSummary: Yatein is a lignan with antiproliferative activity. -
BA2004 BaloxavirSummary: Baloxavir (Baloxaviracid), derived from the precursor Baloxavirmarboxil, is a first-of-its-kind, potent and selective cap-dependent nucleic acid endonuclease inhibitor within the PA subunit of influenza A and B virus polymerase. -
BA2005 PimodivirSummary: Pimodivir (VX-787) is an orally available inhibitor. -
BA2006 TheaflavinSummary: A natural inhibitor of influenza A neuraminidase. -
BA2007 KIN1148Summary: KIN1148 is a small molecule agonist. -
BA2008 ThymalfasinSummary: Thymalfasin (thymosin-alpha1) is an immunomodulatory compound.

